Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.
Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK.
Eur J Med Chem. 2018 Oct 5;158:25-33. doi: 10.1016/j.ejmech.2018.08.089. Epub 2018 Aug 31.
The trans-sialidase protein expressed by Trypanosoma cruzi is an important enzyme in the life cycle of this human pathogenic parasite and is considered a promising target for the development of new drug treatments against Chagas' disease. Here we describe α-amino phosphonates as a novel class of inhibitor of T. cruzi trans-sialidase. Molecular modelling studies were initially used to predict the active-site binding affinities for a series of amino phosphonates, which were subsequently synthesised and their ICs determined in vitro. The measured inhibitory activities show some correlation with the predictions from molecular modelling, with 1-napthyl derivatives found to be the most potent inhibitors having ICs in the low micromolar range. Interestingly, kinetic analysis of the mode of inhibition demonstrated that the α-aminophosphonates tested here operate in a non-competitive manner.
克氏锥虫表达的转涎酶蛋白是这种人体寄生虫生命周期中的一种重要酶,被认为是开发治疗恰加斯病的新药的有前途的靶标。在这里,我们将α-氨基膦酸酯描述为一种新型的克氏锥虫转涎酶抑制剂。最初使用分子建模研究来预测一系列氨基膦酸酯在活性部位的结合亲和力,随后合成并在体外测定其 IC。测量的抑制活性与分子建模的预测有一定的相关性,1-萘基衍生物被发现是最有效的抑制剂,其 IC 在低微摩尔范围内。有趣的是,抑制模式的动力学分析表明,这里测试的α-氨基膦酸酯以非竞争性方式运作。